Neel Shah

711 total citations
38 papers, 472 citations indexed

About

Neel Shah is a scholar working on Rheumatology, Emergency Medicine and Biomedical Engineering. According to data from OpenAlex, Neel Shah has authored 38 papers receiving a total of 472 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Rheumatology, 10 papers in Emergency Medicine and 9 papers in Biomedical Engineering. Recurrent topics in Neel Shah's work include Cardiac Arrest and Resuscitation (9 papers), Mechanical Circulatory Support Devices (9 papers) and Rheumatoid Arthritis Research and Therapies (9 papers). Neel Shah is often cited by papers focused on Cardiac Arrest and Resuscitation (9 papers), Mechanical Circulatory Support Devices (9 papers) and Rheumatoid Arthritis Research and Therapies (9 papers). Neel Shah collaborates with scholars based in United States, Canada and India. Neel Shah's co-authors include Don S. Dizon, David J. Harrison, Derek Tang, Machaon Bonafede, A Howe, Robert Dufour, Barbara H. Johnson, David J. Harrison, Tao Gu and Gaurav Deshpande and has published in prestigious journals such as Blood, Cancer Research and Journal of the American Medical Informatics Association.

In The Last Decade

Neel Shah

33 papers receiving 458 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Neel Shah United States 13 118 114 100 57 53 38 472
Diana Sun United States 11 85 0.7× 43 0.4× 161 1.6× 68 1.2× 127 2.4× 34 600
Greg Carney Canada 12 75 0.6× 133 1.2× 46 0.5× 55 1.0× 118 2.2× 37 620
Diogo Mendes Portugal 16 129 1.1× 71 0.6× 66 0.7× 19 0.3× 116 2.2× 40 796
Marie‐Blanche Valnet‐Rabier France 13 83 0.7× 50 0.4× 43 0.4× 20 0.4× 97 1.8× 28 478
Vishvas Garg United States 13 52 0.4× 120 1.1× 107 1.1× 49 0.9× 27 0.5× 48 469
Mo Dimbil United States 6 41 0.3× 70 0.6× 47 0.5× 36 0.6× 37 0.7× 7 455
Christopher Sanders United States 11 134 1.1× 128 1.1× 48 0.5× 81 1.4× 123 2.3× 18 833
Xiaomei Gu United States 12 154 1.3× 23 0.2× 41 0.4× 31 0.5× 77 1.5× 31 685
Mike Gorenchtein United States 5 54 0.5× 25 0.2× 58 0.6× 25 0.4× 72 1.4× 11 427
Anand Rajeswaran Switzerland 6 102 0.9× 176 1.5× 140 1.4× 18 0.3× 70 1.3× 6 884

Countries citing papers authored by Neel Shah

Since Specialization
Citations

This map shows the geographic impact of Neel Shah's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Neel Shah with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Neel Shah more than expected).

Fields of papers citing papers by Neel Shah

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Neel Shah. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Neel Shah. The network helps show where Neel Shah may publish in the future.

Co-authorship network of co-authors of Neel Shah

This figure shows the co-authorship network connecting the top 25 collaborators of Neel Shah. A scholar is included among the top collaborators of Neel Shah based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Neel Shah. Neel Shah is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Joram, Nicolas, Ravi R. Thiagarajan, Melania M. Bembea, et al.. (2025). Can we reduce the risk of neurological injury in critically ill children on initiation of ECLS? A narrative review of potential modifiable factors. Perfusion. 40(1_suppl). 29S–38S.
3.
Zhu, D. H., et al.. (2024). Multi-modal prediction of extracorporeal support—a resource intensive therapy, utilizing a large national database. JAMIA Open. 8(1). ooae158–ooae158. 1 indexed citations
4.
Said, Ahmed S., et al.. (2023). Assisting Clinical Decisions for Scarcely Available Treatment via Disentangled Latent Representation. arXiv (Cornell University). 5360–5371. 1 indexed citations
6.
Shah, Neel, et al.. (2022). Multi-horizon predictive models for guiding extracorporeal resource allocation in critically ill COVID-19 patients. Journal of the American Medical Informatics Association. 30(4). 656–667. 4 indexed citations
7.
Shah, Neel & Ahmed S. Said. (2021). Extracorporeal Support Prognostication—Time to Move the Goal Posts?. Membranes. 11(7). 537–537. 8 indexed citations
9.
Lamerato, Lois, Kathryn Richert-Boe, Devi Sundaresan, et al.. (2020). Risk of chemotherapy-induced febrile neutropenia in patients with metastatic cancer not receiving granulocyte colony-stimulating factor prophylaxis in US clinical practice. Supportive Care in Cancer. 29(4). 2179–2186. 25 indexed citations
11.
Wakeam, Elliot, George Molina, Neel Shah, et al.. (2017). Variation in the cost of 5 common operations in the United States. Surgery. 162(3). 592–604. 33 indexed citations
12.
Gu, Tao, Neel Shah, Gaurav Deshpande, Derek Tang, & D. Eisenberg. (2016). Comparing Biologic Cost Per Treated Patient Across Indications Among Adult US Managed Care Patients: A Retrospective Cohort Study. Drugs - Real World Outcomes. 3(4). 369–381. 30 indexed citations
13.
Sauer, Brian C., Tao He, Jianwei Leng, et al.. (2015). Effectiveness and costs of biologics in veterans with rheumatoid arthritis. 7(6). 280–289. 6 indexed citations
14.
Gu, Tao, Neel Shah, Gaurav Deshpande, et al.. (2015). Biologic Cost per Effectively Treated Rheumatoid Arthritis Patient in a Large Managed Care Population: A Retrospective Cohort Study. Journal of health economics and outcomes research. 3(2). 122–131. 2 indexed citations
15.
Bonafede, Machaon, Barbara H. Johnson, Derek Tang, et al.. (2015). Etanercept‐Methotrexate Combination Therapy Initiators Have Greater Adherence and Persistence Than Triple Therapy Initiators With Rheumatoid Arthritis. Arthritis Care & Research. 67(12). 1656–1663. 28 indexed citations
16.
Bonafede, Machaon, Barbara H. Johnson, Nicole Princic, Neel Shah, & David J. Harrison. (2014). Cost-Effectiveness Of Ra Biologics In The Two Years Following Initiation Using A Validated Claims-Based Algorithm In A United States Commercially Insured Population. Value in Health. 17(3). A46–A47.
17.
Howe, A, et al.. (2014). Treatment Patterns and Annual Drug Costs of Biologic Therapies Across Indications from the Humana Commercial Database. Journal of Managed Care Pharmacy. 20(12). 1236–1244. 44 indexed citations
18.
Bonafede, Machaon, Barbara H. Johnson, Nicole Princic, Neel Shah, & David J. Harrison. (2014). Cost per patient-year in response using a claims-based algorithm for the 2 years following biologic initiation in patients with rheumatoid arthritis. Journal of Medical Economics. 18(5). 376–389. 15 indexed citations
19.
Shah, Neel, et al.. (2012). Characteristics of Alprazolam‐Related Deaths Compiled by a Centralized State Medical Examiner. American Journal on Addictions. 21(s1). S27–34. 13 indexed citations
20.
Shah, Neel, Joel Halverson, & Suresh Madhavan. (2012). Burden of Emergency and Non-emergency Colorectal Cancer Surgeries in West Virginia and the USA. Journal of Gastrointestinal Cancer. 44(1). 46–53. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026